Tolfine 80 mg/ml solution for injection for cattle
Tolfine 80 mg/ml solution for injection for cattle
Authorised
- Tolfenamic acid
Product identification
Medicine name:
Tolfine 80 mg/ml solution for injection for cattle
Tolfine, 80 mg/ml, injekcinis tirpalas galvijams
Active substance:
- Tolfenamic acid
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Tolfenamic acid80.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal20day
-
Milk0hour
-
-
-
Intravenous use
-
Cattle
-
Meat and offal4day
-
Milk12hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Amber type I glass vial closed with chlorobutyl rubber stoppers and oversealed with an aluminium seal with a polypropylene flip-off cap.Each vial is packaged in a cardboard box.Package sizes:Cardboard box with 1 vial of 250 ml
- Amber type I glass vial closed with chlorobutyl rubber stopper and oversealed with an aluminium seal with a polypropylene flip-off cap.Each vial is packaged in a cardboard box.Package sizes:Cardboard box with 1 vial of 100 ml
- Amber type I glass vial closed with chlorobutyl rubber stopper and oversealed with an aluminium seal with a polypropylene flip-off cap.Each vial is packaged in a cardboard box.Package sizes:Cardboard box with 1 vial of 50 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol S.A.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/22/2720/001-003
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0661/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 25/09/2024
Lithuanian (PDF)
Published on: 3/12/2024
How useful was this page?: